首页> 外国专利> Vaccine compositions comprising lipooligosaccharides of inmunotipo L2 L3 and / or from Neisseria minigitidis LGBT

Vaccine compositions comprising lipooligosaccharides of inmunotipo L2 L3 and / or from Neisseria minigitidis LGBT

机译:疫苗组合物,其包含小肠奈瑟氏菌LGBT和/或小肠奈瑟氏球菌LGBT的脂寡糖

摘要

1. - Nissl agent extracted from Nissl strains with L2 immunity or Nissl strains with L3 immunity, in which ECA is igtb;Or a lactone preparation process, including the mixing of vesicles produced from a visceral strain with a L2 Los immunology and a L3 Los immunology neissal strain, Each strain can be selected as igtb.16: an immune ingredient or vaccine, including the preparation of Neisseria blisters, the preparation of 1-10 or 12-15 of any required water bottle and an acceptable former pharmacist 19. Neisseria separated the water bottle from claim 16, which relates to the separation of the water bottle from the ECA (s) production phase and claim 11 of Neisseria,Or, if appropriate, combine the L2 and L3 blisters and prepare the blisters with a pharmaceutically acceptable precursor chemical.
机译:1.-从EC2为igtb的具有L2免疫力的Nissl菌株或具有L3免疫力的Nissl菌株中提取的Nissl剂;或内酯制备过程,包括将具有L2 Los免疫学和L3 Los的内脏菌株产生的囊泡混合免疫学奈瑟菌菌株,每种菌株均可以选择作为igtb.16:一种免疫成分或疫苗,包括制备奈瑟氏菌水泡,制备1-10或12-15的任何所需水瓶以及可接受的前药剂师19。将水瓶与权利要求16中的水瓶分开,该水瓶与ECA生产阶段和奈瑟氏球菌的权利要求11中的水瓶分离有关,或者(如果合适的话)将L2和L3水泡合并并用药学上可接受的水泡制备水泡前体化学品。

著录项

  • 公开/公告号CO5680456A2

    专利类型

  • 公开/公告日2006-09-29

    原文格式PDF

  • 申请/专利权人 GLAXOSMITHKLINE BIOLOGICALS S.A.;

    申请/专利号CO20050007268

  • 发明设计人 POOLMAN JAN;

    申请日2005-01-28

  • 分类号A61K39;A61K39/095;A61K39/102;A61P37/04;C07K14/22;C12N1/21;

  • 国家 CO

  • 入库时间 2022-08-21 21:39:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号